A Single Arm Pilot Study of Azacitidine in Myelodysplastic Syndromes (MDS) / Acute Myeloid Leukaemia (AML), With Eltrombopag Support for Thrombocytopenia

Clinical trial NCT01488565 · COMPLETED

Trial details

NCT number: NCT01488565
Sponsor: Peter MacCallum Cancer Centre, Australia
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes (MDS)Acute Myeloid Leukaemia (AML)

Start date: 2010-12-01
Primary completion: 2014-05-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.